In accordance with Nasdaq Stockholm AB's decision, following application from the liquidator of Scandion Oncology, the shares of Scandion Oncology will be delisted from Nasdaq First North Growth Market. The last day of trading is on July 11, 2025.
For further information, please contact:
Appointed Liquidator
Phone: +45 21227227
E-mail: info@scandiononcology.com
The information was provided by the contact person above for publication on June 25, 2025 at 17.00 CET.
About Scandion
Scandion Oncology (Scandion) is a clinical-stage biotech company using an innovative drug efflux pump inhibition technique with biomodulation capabilities on ABCG2 and UGT1A1 targets to revert drug resistance.
Drug resistance remains a massive problem in cancer treatment and in the development of new medicines. Scandion's lead compound SCO-101 is currently studying metastatic colorectal cancer (mCRC) in its Phase 2 CORIST trial, while the PANTAX Phase 1 program is developing SCO-101 for pancreatic cancer.
Scandion is based in Copenhagen and is listed on Nasdaq First North Growth Market Sweden (ticker: SCOL). Vator Securities is the Company's certified advisor on Nasdaq First North Growth Market.
Aktien»Nachrichten»SCANDION ONCOLOGY A/S»Scandion Oncology A/S: Delisting of the shares of Scandion Oncology - last day of trading July 11, 2025
Scandion Oncology A/S: Delisting of the shares of Scandion Oncology - last day of trading July 11, 2025
© 2025 GlobeNewswire (Europe)
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.07. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.07.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 14.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.07.2025ISIN NameDK0061031895 SCANDION... ► Artikel lesen | |
| 14.07. | XFRA 8VY: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSCANDION ONC. DK-... ► Artikel lesen | |
| 25.06. | Scandion Oncology A/S: Delisting of the shares of Scandion Oncology - last day of trading July 11, 2025 | In accordance with Nasdaq Stockholm AB's decision, following application from the liquidator of Scandion Oncology, the shares of Scandion Oncology will be delisted from Nasdaq First North Growth Market.... ► Artikel lesen | |
| 25.06. | The observation status for Scandion Oncology A/S is updated | On February 27, 2025, the shares in Scandion Oncology A/S (the "Company") were given observation status with reference to information that the Company's board of directors would, if a partnership... ► Artikel lesen | |
| 25.06. | Scandion Oncology A/S: Scandion Oncology has applied for delisting of the company's shares from Nasdaq First North Growth Market | The liquidator of Scandion Oncology (the "Company") has today submitted an application for delisting of the Company's shares from Nasdaq First North Growth Market. The last day of trading in the Company's... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.